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Researchers are exploring better treatments in cancer. The identification of active plant
chemicals and the study of their biological activities are extensively being pursued. The
five objectives in this study were to determine the antioxidant activity of rice bran
extracts, to isolate oryzanol from rice bran, to determine the cytotoxicity activity of
oryzanol, stigmasterol and microminutinin, to investigate the morphological changes in
MCF7 cells treated with oryzanol, stigmasterol and microminutinin and to study on the
effect of these compounds on c-myc, c-fos and c-erbB2 gene expression. The
antioxidant activities of various rice bran extracts were carried out to determine the best
organic solvent extraction. In the Ferric Thiocyanate (FTC) and Thiobarbiturate (TBA)
assays, chloroform extract (FTC; 92%, TBA; 82%) had the highest antioxidant activity
followed by ethyl acetate (FTC;90%, TBA;79%) methanol (FTC;90%, TBA;79%) and
hexane (FTC; 89%, TBA;77%) extracts. The antioxidant activities in the ~-carotene
degradation assay gave similar findings. Comparison between the antioxidant activities
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of the hexane extract (non polar lipid) and chloroform: methanol (2:1) extract (total lipid)
were then determined. The extraction time (0.5 and 1 hour) and temperature (33° and
60°C) were differed to gain the optimum method of extractions. Overall, the total lipid
had higher antioxidant activity than the non polar lipid. The extraction time of 30
minutes and 33°C extraction temperature gave the highest antioxidant activity (97%).
The total lipid was further investigated by varying the solvent to bran ratio 4: 1 and 5: 1
(v/w). Extraction time of thirty minutes, extraction temperature of 29°C and solvent to
bran ratio (v/w) gave the highest antioxidant activity (15%). The oryzanol content in the
rice bran was determined using high performance liquid chromatography (HPLC). In
this study, extraction and saponification temperature at 29°C gave the highest yield of
oryzanol (3964 ± 33 mg/kg). Under this condition, oryzanol was extracted using
preparative HPLC. Oryzanol, stigmasterol and microminutinin were then tested for their
free radical scavenging effect. Oryzanol gave the highest antioxidant activity followed
by stigmasterol and microminutinin. Cytotoxicity assay of oryzanol, stigmasterol and
microminutinin were then used on various cancer cell lines MCF7, MDA-MB-231,
HepG2, Caco-2, Caov-3, HeLa, Chang and 3T3. The ICso for oryzanol in MCF7 was
the lowest (53.5±1.3 ~g/ml). Stigmasterol inhibited colon cancer the best with ICso at
132.5±3.3 ~M. From all of the cancer cell lines, microminutinin exhibited anti-
proliferative activity on MCF7 with ICso at 203.0±4.0~M. Confocal microscopy using
acridine orange and propodium iodide staining of treated MCF7 with oryzanol,
stigmasterol and microminutinin showed nucleus fragmentation at 48 hours. Light
microscopy of treated MCF7 using modified TUNEL assay showed dark stained
apoptotic nuclei. For the Fluorometric TUNEL assay, intense yellow fluorescence of PI-
FITC was observed at 24 hours. After 48 and 72 hours of treatment, apoptotic bodies
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were visibly seen in all treatments. In the flow cytometry analysis, the RNAse/PI
treatment in the treated MCF7 cells showed a marked decrease of G] phase and an
Increase in the apoptotic cells with increased concentration. Annexin V-FITC/PI
staining showed an increase of early and late apoptotic cells in oryzanol-treated
compared to increment of only early apoptotic cells in stigmasterol and microminutinin-
treated MCF7 after 24 hours. After 48 hours, the percentages of late apoptotic cells in
all treated cells were increased. Oryzanol and stigmasterol suppressed the oncogene c-
fos, c-erbB2 and c-myc expression. Microminutinin only suppressed the oncogene c-fos
and c-myc expression. In conclusion, the three compounds were shown to be anti-
proliferative agents.
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Peru batan dan Sains Kesihatan
Para penyelidik berusaha untuk mencari penyelesaian bagi mengubati kanser.
Pengenalpastian kompaun aktif dan kajian tentang aktiviti biologi sedang giat dijalankan.
Terdapat lima objektif iaitu kepastian aktiviti antioksidan di dalam dedak beras,
pengasingan kompaun aktif dari dedak beras, kajian tentang anti-kanser kepada oryzanol,
stigmasterol dan microminutinin, kajian tentang perubahan morfologi dalam sel yang
mengalami apoptosis dan kajian tentang gen terekspres daripada sel yang teraruh.
Dalam kaedah Ferik tiosianate (FTC) dan Tiobarbiturik (TBA) yang digunakan untuk
menentukan peratus antioksidan, ekstrak klorofom (FTC, 92%; TBA, 82%) mempunyai
aktiviti antioksidan yang tertinggi diikuti dengan ekstrak etil asetat (FTC, 90%; TBA,
79%), ekstrak methanol (FTC, 92%; TBA, 82%) dan ekstrak heksana (FTC, 89%; TBA,
77%). Peratusan aktiviti antioksidan di dalam kaedah penurunan beta-karoten
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menunjukkan keputusan yang serupa. Aktiviti antioksidan dari kaedah penurunan beta-
karotene menunjukkan ekstrak klorofom:metanol (2:1) mempunyai aktiviti antioksidan
yang tinggi berbanding dengan ekstrak heksana. Masa pengekstrakan 30 minit dan suhu
33° C memberikan hasil yang tertinggi (8.6%) dan aktiviti antioksidan yang tertinggi
(97%). Ekstrak klorofom:methanol (2:1) juga digunakan untuk melihat ratio larutan
dedak 4:1 dan 5:1 (v/w). Pengekstrakan masa 30 minit, suhu 29°C dan ratio larutan ke
dedak 5:1 (v/w) memberi penghasilan yang tinggi (12.15%) dan aktiviti antioksidan
yang tinggi (15%). Kandungan oryzanol dalam dedak beras ditentukan dengan
menggunakan HPLC. Kebiasaannya, saponifikasi dijalankan pada suhu yang tinggi. Di
sini, suhu pengekstrakan dan saponifikasi pada 29°C memberi penghasilan oryzanol
yang tertinggi (3964 ± 33 mg/kg). Di dalam keadaan ini, oryzanol dihasilkan
menggunakan kolum HPLC preparatif. Aktiviti oksidan oryzanol, stigmasterol dan
microminutinin diuji dalam kaedah DPPH. Oryzanol memberi aktiviti antioksidan yang
tertinggi diikuti dengan stigmasterol dan microminutinin. Asai sitotoksik dijalankan
menggunakan pelbagai titisan sel kanser MCF7, MDA-MB-231, HepG2, Caco-2, Caov-
3, HeLa, Chang dan 3T3. Oryzanol memberi ICso terendah kepada MCF7 (53.5±1.3
Ilg/ml). Stigmasterol menghalang pertumbuhan kanser kolon pada 132.5±3.3 IlM.
Microminutinin menghalang kanser MCF7 pada 203.0±4.0 IlM. Konfokal mikroskopi
digunakan untuk melihat perubahan morfologi MCF7 yang normal dan yang diberi
ketiga-tiga kompaun dalam kaedah akridin oren dan propodium iodid. Kesemua
perlakuan menunjukkan fragmentasi nukleus pada 48 jam. Mikroskopi cahaya
digunakan untuk melihat fragmentasi nukleus yang telah diwamakan gelap di dalam
TUNEL asai yang dimodifikasikan. Mikroskopi pendaflour dan konfokal digunakan
untuk melihat kesan fragmentasi nukleus yang dihasilkan oleh perlakuan ketiga-tiga
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"kompoun. Perlakuan dua puluh jam memperlihatkan pendaflour kuning yang terang
dihasilkan oleh Propodium Iodide-FITC. Perlakuan 48 dan 72 jam memperlihatkan
fragmentasi nukleus. Di dalam analisa flow sitometri, pengurangan peratus pada fasa
G1 dan peningkatan peratusan sel apoptotik dilihat. Penglabelan annexin V-FITC/PI
selepas 24 jam menunjukkan peningkatan sel apoptotik awal dan sel apoptotik akhir
pada sel yang diberi oryzanol berbanding dengan peningkatan sel apoptotik awal sahaja
pada sel yang diberi stigmasterol dan microminutinin. Selepas 48 jam, peratusan sel
apoptotik akhir pada kesemua sel yang diberi ketiga-tiga kompaun meningkat.
Perlakuan oryzanol dan stigmasterol ke atas sel MCF7 mengurangkan ekspresi c-myc, c-
fos dan c-erbB2. Microminutinin mengurangkan ekspresi c-myc dan c-fos sahaja.
Kesimpulannya, ketiga-tiga kompoun berpotensi menjadi agen anti-proliferasi.
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CHAPTER I
INTRODUCTION
Cancer is one of the three main causes of death among the economically active
populations. The two other main causes of mortality worldwide are accidents and
cardiovascular diseases. Annually, there are more than 6 million deaths from a type
of cancer worldwide (Tovar-Guzman et al., 200 I). The number of new cancer cases
has been increasing over the past nine decades. It was reported that cancer (45%) is
the major cause of death in Government Hospitals, which is 2.8 times higher than
that of the heart diseases (16%) (Rosemawati and Sallehudin, 2001). A total of
26,089 cancers were diagnosed among all residents in Peninsular Malaysia in the
year 2002, comprising 11,815 males and 14,274 females. An estimated 10,656 cases
were however not registered. In terms of risk, 1 in 5.5 Malaysians can be expected to
get cancer in hislher lifetime. Taking into account the unregistered cases, the risk
would be 1 in 4 Malaysians. The crude rate for all cancers in the year 2002 was 118.9
per 100,000 males and 148.4 per 100,000 females (Lim et al., 2002).
Among all types of cancer, breast cancer is the most common malignancy affecting
women and the second highest cause of cancer death (Sakorafas et al., 2002). Every
woman is at risk for getting breast cancer. Close to 200,000 cases of breast cancer
were diagnosed in the United States in 2001. In 2003, an estimated 211,000 women
were diagnosed with breast cancer. Breast cancer is the second leading cause of
cancer death in American women after lung cancer. Breast cancer affects more than
1,000 men in United States each year. The lifetime risk of any particular woman
getting breast cancer is about 1 in 8 although the lifetime risk of dying from breast
cancer is much lower at 1 in 28 (Jatoi and Miller, 2003). The National Cancer
Registry of Malaysia reported 4337 cases of female breast cancer making it the most
commonly diagnosed cancer in Malaysian women. Breast cancer is the commonest
cancer in all ethnic groups and all age group in females from the age of 20 years
(Lim et al., 2002).
Research has led to better treatments in cancer. Researchers are learning more about
what causes cancer and are exploring new ways to prevent, detect, diagnose, and
treat this disease (Jayaprakasam et al., 2003). Even though numerous early works,
including classical Greek and Latin texts and mediaeval Latin herbals, record the
value of many plant species for treating all kind of diseases, few of these have been
investigated in the context of modem biology (Wang and Xu, 1995). Furthermore,
modem medicine has mostly abandoned plants as a source of new medicines in
favour of chemical synthesis. The problem is that many drugs, particularly for
cancer, are not as effective or free from unwanted side effects as they might be.
However, recently modem pharmacognosy has been used in a judicious association
with the ancient data. The identification of active plant chemicals is an essential
component of modem pharmacognosy. The biological activity and clinical value of
the whole plant, as in medicinal herbalism, is also being pursued (Pasquale, 1984).
Whole grains contain many of the same compounds and therefore may share some of
the beneficial properties of fruits and vegetables (Jacobs et al., 1995). In one study,
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grain consumption has been inversely associated with colorectal cancer (Annstrong
and Doll, 1975). The grains include wheat and rice. One of the objectives of this
study will look at the potential anti-cancer effect of rice bran. This is given attention
because rice bran was once considered as one of the most wasted food resources and
was only used as diet for the laying hens. Since rice is heavily consumed in this
country, this country produces a lot of the milling by-product that is the rice bran.
One of the few bioactive compounds being studied is plant sterols. Plant sterols
(phytosterols) such as sitosterol and stigmasterol are ubiquitous in occurrence in
higher plants (Tapeiro et al., 2003). They are structurally similar to cholesterol,
differing only by a methyl or ethyl group in their side chains. Thus, they are able to
inhibit the uptake of cholesterol from the small intestine (Neil and Huxley, 2002) and
rendering them to be anti-hypercholesterolemic (Normen et al., 2001). On the other
had, it was reported on their ability to prevent colorectal cancer (Normen et al.,
2001). Another bioactive compound that is currently being looked into is oryzanol.
It is a ferulate ester of triterpene alcohols and plant sterols. This compound is also
able to reduce hypercholesterolemia (Rogers et al., 1993). Coumarins, a family of
phenylpropanoids, are among the naturally occurring phenolic compounds that are
being investigated. Only one earlier study had reported on its effect in lung cancer
(Lopez-Gonzalez et aI., 2004).
New advances in understanding cancer provide the basis for screening bioactive
plant chemicals using relevant bioassays. Procedures which are simple, rapid and
3
